Skip to main content
main-content
Erschienen in: Endocrine 2/2022

02.07.2022 | Original Article

Interaction effect of blood glucose and pressure on the risk of chronic kidney disease: a population-based prospective cohort study

verfasst von: Minzhen Wang, Miao Xia, Hongyan Yang, Desheng Zhang, Yanan Zhao, Yingqian He, Jing Liu, Lulu Zhang, Chun Yin, Yana Bai

Erschienen in: Endocrine | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the interaction effect of blood glucose and blood pressure on the risk of chronic kidney disease (CKD).

Methods

31,165 subjects were selected without CKD at baseline and had completed the first follow-up from “Jinchang cohort”. Cox regression model and restricted cubic splines functions were used to evaluate the effects of blood glucose or pressure on the incidence of CKD and dose-response relationship after adjusting for confounding covariates. Synergic effect was assessed by the multiplicative or additive interaction scale.

Results

Among 31,165 subjects, 1307 new-onset CKD were observed during 68905.78 person-years follow-up, and the incidence density was 18.97 per 1000 person-years. The risk of CKD gradually increased with the increase of blood pressure in diabetes, pre-diabetes and normal groups (Ptrend < 0.05). And, the risk was greatest when SBP/DBP reached ≥150/≥110 mmHg in three groups, and HRs (95% CI) were 1.610 (1.070–2.422), 2.142 (1.396–3.288) and 2.455 (1.941–3.106), respectively. Additionally, among hypertension, pre-hypertension and normal groups, the risk of CKD increased by 16.0%, 14.3% and 25.2% for each 1 mmol/L of FPG. When FPG level was more than 9.0 mmol/L, the risk was greatest and adjusted HRs (95% CI) were 2.856 (2.176–3.748), 2.979 (1.828–4.854) and 7.520 (4.517–12.519). Furthermore, the risk was highest when hypertension was accompanied by diabetes (HR = 4.915, 95% CI: 3.923–6.157). This analysis supported a less than multiplicative effect (HR = 0.634, 95% CI: 0.417–0.964) for the interaction term of diabetes and hypertension, while there was no additive interaction towards CKD in all interaction term.

Conclusions

Blood glucose and pressure were independent risk factors in incidence of CKD, but there was only a negative multiplicative interaction between hypertension and diabetes, but no additive interaction effect between them.
Literatur
1.
Zurück zum Zitat N.R. Hill, S.T. Fatoba, J.L. Oke et al. Global Prevalence of Chronic Kidney Disease—A Systematic Review and Meta-Analysis. PloS one 11(7), e0158765 (2016) PubMedPubMedCentralCrossRef N.R. Hill, S.T. Fatoba, J.L. Oke et al. Global Prevalence of Chronic Kidney Disease—A Systematic Review and Meta-Analysis. PloS one 11(7), e0158765 (2016) PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat R. Lozano, M. Naghavi, K. Foreman et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859), 2095–2128 (2012) PubMedCrossRef R. Lozano, M. Naghavi, K. Foreman et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859), 2095–2128 (2012) PubMedCrossRef
3.
Zurück zum Zitat L. Zhang, F. Wang, L. Wang et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818), 815–822 (2012) PubMedCrossRef L. Zhang, F. Wang, L. Wang et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818), 815–822 (2012) PubMedCrossRef
4.
Zurück zum Zitat C.E. Koro, B.H. Lee, S.J. Bowlin, Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clin. Therapeutics 31(11), 2608–2617 (2009) CrossRef C.E. Koro, B.H. Lee, S.J. Bowlin, Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clin. Therapeutics 31(11), 2608–2617 (2009) CrossRef
5.
Zurück zum Zitat K. Al-Rubeaan, A.M. Youssef, S.N. Subhani et al. Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. PloS one 9(2), e88956 (2014) PubMedPubMedCentralCrossRef K. Al-Rubeaan, A.M. Youssef, S.N. Subhani et al. Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. PloS one 9(2), e88956 (2014) PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat P.A. Sarafidis, S. Li, S.C. Chen et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am. J. Med. 121(4), 332–340 (2008) PubMedCrossRef P.A. Sarafidis, S. Li, S.C. Chen et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am. J. Med. 121(4), 332–340 (2008) PubMedCrossRef
7.
Zurück zum Zitat J.M. Pascual, E. Rodilla, C. Gonzalez et al. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension 45(6), 1125–1130 (2005) PubMedCrossRef J.M. Pascual, E. Rodilla, C. Gonzalez et al. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension 45(6), 1125–1130 (2005) PubMedCrossRef
8.
Zurück zum Zitat O. Torffvit, C.D. Agardh, The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients. J. Diabet Complicat. 15(6), 307–313 (2001) CrossRef O. Torffvit, C.D. Agardh, The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients. J. Diabet Complicat. 15(6), 307–313 (2001) CrossRef
9.
Zurück zum Zitat J. Liu, D. Zhao, J. Liu et al. Prevalence of diabetes mellitus in outpatients with essential hypertension in China: a cross-sectional study. BMJ open 3(11), e003798 (2013) PubMedPubMedCentralCrossRef J. Liu, D. Zhao, J. Liu et al. Prevalence of diabetes mellitus in outpatients with essential hypertension in China: a cross-sectional study. BMJ open 3(11), e003798 (2013) PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat A.D. Colosia, R. Palencia, S. Khan, Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabet. Metab. Syndr. Obes. 6, 327–338 (2013) CrossRef A.D. Colosia, R. Palencia, S. Khan, Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabet. Metab. Syndr. Obes. 6, 327–338 (2013) CrossRef
11.
Zurück zum Zitat Z. Wang, J.M. do Carmo, N. Aberdein et al. Synergistic Interaction of Hypertension and Diabetes in Promoting Kidney Injury and the Role of Endoplasmic Reticulum Stress. Hypertension 69(5), 879–891 (2017) PubMedCrossRef Z. Wang, J.M. do Carmo, N. Aberdein et al. Synergistic Interaction of Hypertension and Diabetes in Promoting Kidney Injury and the Role of Endoplasmic Reticulum Stress. Hypertension 69(5), 879–891 (2017) PubMedCrossRef
12.
Zurück zum Zitat W. Shi, H. Wang, Y. Zhou et al. Synergistic interaction of hypertension and diabetes on chronic kidney disease: Insights from the National Health and Nutrition Examination Survey 1999-2006. J. Diabet Complicat. 34(2), 107447 (2020) CrossRef W. Shi, H. Wang, Y. Zhou et al. Synergistic interaction of hypertension and diabetes on chronic kidney disease: Insights from the National Health and Nutrition Examination Survey 1999-2006. J. Diabet Complicat. 34(2), 107447 (2020) CrossRef
13.
Zurück zum Zitat S. Erfanpoor, K. Etemad, S. Kazempour et al. Diabetes, Hypertension, and Incidence of Chronic Kidney Disease: Is There any Multiplicative or Additive Interaction? Int. J. Endocrinol. Metab. 19(1), e101061 (2021) PubMed S. Erfanpoor, K. Etemad, S. Kazempour et al. Diabetes, Hypertension, and Incidence of Chronic Kidney Disease: Is There any Multiplicative or Additive Interaction? Int. J. Endocrinol. Metab. 19(1), e101061 (2021) PubMed
14.
Zurück zum Zitat Y. Bai, A. Yang, H. Pu et al. Cohort Profile: The China Metal-Exposed Workers Cohort Study (Jinchang Cohort). Int. J. Epidemiol. 46(4), 1095–1096e (2017) PubMed Y. Bai, A. Yang, H. Pu et al. Cohort Profile: The China Metal-Exposed Workers Cohort Study (Jinchang Cohort). Int. J. Epidemiol. 46(4), 1095–1096e (2017) PubMed
15.
Zurück zum Zitat N.K. Foundation, KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am. J. Kidney Dis.: Off. J. Natl Kidney Found. 66(5), 884–930 (2015) CrossRef N.K. Foundation, KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am. J. Kidney Dis.: Off. J. Natl Kidney Found. 66(5), 884–930 (2015) CrossRef
16.
17.
Zurück zum Zitat T. A. D. Association. 2, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 41(Suppl 1), S13–s27 (2018) T. A. D. Association. 2, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 41(Suppl 1), S13–s27 (2018)
18.
Zurück zum Zitat L.S. Liu, 2010 Chinese guidelines for the management of hypertension. Chin. J. Hypertens. 19(08), 701–743 (2011) L.S. Liu, 2010 Chinese guidelines for the management of hypertension. Chin. J. Hypertens. 19(08), 701–743 (2011)
19.
Zurück zum Zitat L. Desquilbet, F. Mariotti, Dose-response analyses using restricted cubic spline functions in public health research. Stat. Med. 29(9), 1037–1057 (2010) PubMed L. Desquilbet, F. Mariotti, Dose-response analyses using restricted cubic spline functions in public health research. Stat. Med. 29(9), 1037–1057 (2010) PubMed
20.
Zurück zum Zitat T. Andersson, L. Alfredsson, H. Källberg et al. Calculating measures of biological interaction. Eur. J. Epidemiol. 20(7), 575–579 (2005) PubMedCrossRef T. Andersson, L. Alfredsson, H. Källberg et al. Calculating measures of biological interaction. Eur. J. Epidemiol. 20(7), 575–579 (2005) PubMedCrossRef
21.
Zurück zum Zitat R. de Mutsert, K.J. Jager, C. Zoccali et al. The effect of joint exposures: examining the presence of interaction. Kidney Int. 75(7), 677–681 (2009) PubMedCrossRef R. de Mutsert, K.J. Jager, C. Zoccali et al. The effect of joint exposures: examining the presence of interaction. Kidney Int. 75(7), 677–681 (2009) PubMedCrossRef
22.
Zurück zum Zitat R.W. Schrier, R.O. Estacio, A. Esler et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 61(3), 1086–1097 (2002) PubMedCrossRef R.W. Schrier, R.O. Estacio, A. Esler et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 61(3), 1086–1097 (2002) PubMedCrossRef
23.
Zurück zum Zitat P.A. James, S. Oparil, B.L. Carter et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama 311(5), 507–520 (2014) PubMedCrossRef P.A. James, S. Oparil, B.L. Carter et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama 311(5), 507–520 (2014) PubMedCrossRef
24.
Zurück zum Zitat N.B. Shulman, C.E. Ford, W.D. Hall et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13(5 Suppl), I80–I93 (1989) PubMed N.B. Shulman, C.E. Ford, W.D. Hall et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13(5 Suppl), I80–I93 (1989) PubMed
25.
Zurück zum Zitat H.M. Perry Jr, J.P. Miller, J.R. Fornoff et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25(4 Pt 1), 587–594 (1995) PubMedCrossRef H.M. Perry Jr, J.P. Miller, J.R. Fornoff et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25(4 Pt 1), 587–594 (1995) PubMedCrossRef
26.
Zurück zum Zitat W.G. Walker, J.D. Neaton, J.A. Cutler et al. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. Jama 268(21), 3085–3091 (1992) PubMedCrossRef W.G. Walker, J.D. Neaton, J.A. Cutler et al. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. Jama 268(21), 3085–3091 (1992) PubMedCrossRef
27.
Zurück zum Zitat P. Muntner, A. Anderson, J. Charleston et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am. J. Kidney Dis. 55(3), 441–451 (2010) PubMedCrossRef P. Muntner, A. Anderson, J. Charleston et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am. J. Kidney Dis. 55(3), 441–451 (2010) PubMedCrossRef
28.
Zurück zum Zitat A.J. Collins, R.N. Foley, B. Chavers et al. ‘United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am. J. Kidney Dis. 59(1 Suppl 1), A7, e1–420 (2012) A.J. Collins, R.N. Foley, B. Chavers et al. ‘United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am. J. Kidney Dis. 59(1 Suppl 1), A7, e1–420 (2012)
29.
Zurück zum Zitat A.K. Bidani, A.J. Polichnowski, R. Loutzenhiser et al. Renal microvascular dysfunction, hypertension and CKD progression. Curr. Opin. Nephrol. Hypertension 22(1), 1–9 (2013) CrossRef A.K. Bidani, A.J. Polichnowski, R. Loutzenhiser et al. Renal microvascular dysfunction, hypertension and CKD progression. Curr. Opin. Nephrol. Hypertension 22(1), 1–9 (2013) CrossRef
30.
Zurück zum Zitat H.A. Koomans, J.C. Roos, P. Boer et al. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension 4(2), 190–197 (1982) PubMedCrossRef H.A. Koomans, J.C. Roos, P. Boer et al. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension 4(2), 190–197 (1982) PubMedCrossRef
31.
Zurück zum Zitat E. Pimenta, K.K. Gaddam, S. Oparil et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 54(3), 475–481 (2009) PubMedCrossRef E. Pimenta, K.K. Gaddam, S. Oparil et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 54(3), 475–481 (2009) PubMedCrossRef
32.
Zurück zum Zitat K. Iseki, Y. Ikemiya, K. Kinjo et al. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan. Clin. Exp. Nephrol. 8(3), 250–256 (2004) PubMedCrossRef K. Iseki, Y. Ikemiya, K. Kinjo et al. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan. Clin. Exp. Nephrol. 8(3), 250–256 (2004) PubMedCrossRef
33.
Zurück zum Zitat X. Wang, F. Fan, J. Jia et al. Association of different glucose traits with kidney function decline risk in a Chinese community-based population without chronic kidney disease. Ther. Clin. Risk Manag 14, 1725–1734 (2018) PubMedPubMedCentralCrossRef X. Wang, F. Fan, J. Jia et al. Association of different glucose traits with kidney function decline risk in a Chinese community-based population without chronic kidney disease. Ther. Clin. Risk Manag 14, 1725–1734 (2018) PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat P. Khajehdehi, L. Malekmakan, M. Pakfetrat et al. Prevalence of chronic kidney disease and its contributing risk factors in southern Iran: a cross-sectional adult population-based study. Iran. J. kidney Dis. 8(2), 109–115 (2014) PubMed P. Khajehdehi, L. Malekmakan, M. Pakfetrat et al. Prevalence of chronic kidney disease and its contributing risk factors in southern Iran: a cross-sectional adult population-based study. Iran. J. kidney Dis. 8(2), 109–115 (2014) PubMed
35.
Zurück zum Zitat K. Yamagata, K. Ishida, T. Sairenchi et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 71(2), 159–166 (2007) PubMedCrossRef K. Yamagata, K. Ishida, T. Sairenchi et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 71(2), 159–166 (2007) PubMedCrossRef
36.
Zurück zum Zitat E.I. Ekinci, G. Jerums, A. Skene et al. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabet. Care 36(11), 3620–3626 (2013) CrossRef E.I. Ekinci, G. Jerums, A. Skene et al. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabet. Care 36(11), 3620–3626 (2013) CrossRef
37.
Zurück zum Zitat R. Ikee, Y. Hamasaki, M. Oka et al. Glucose metabolism, insulin resistance, and renal pathology in non-diabetic chronic kidney disease. Nephron Clin. Pract. 108(2), c163–c168 (2008) PubMedCrossRef R. Ikee, Y. Hamasaki, M. Oka et al. Glucose metabolism, insulin resistance, and renal pathology in non-diabetic chronic kidney disease. Nephron Clin. Pract. 108(2), c163–c168 (2008) PubMedCrossRef
38.
Zurück zum Zitat M. Nangaku, Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern. Med. 43(1), 9–17 (2004) PubMedCrossRef M. Nangaku, Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern. Med. 43(1), 9–17 (2004) PubMedCrossRef
39.
Zurück zum Zitat D.H. Kang, J. Kanellis, C. Hugo et al. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 13(3), 806–816 (2002) PubMedCrossRef D.H. Kang, J. Kanellis, C. Hugo et al. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 13(3), 806–816 (2002) PubMedCrossRef
40.
Zurück zum Zitat R. Michishita, T. Matsuda, S. Kawakami et al. Hypertension and hyperglycemia and the combination thereof enhances the incidence of chronic kidney disease (CKD) in middle-aged and older males. Clin. Exp. Hypertens. 39(7), 645–654 (2017) PubMedCrossRef R. Michishita, T. Matsuda, S. Kawakami et al. Hypertension and hyperglycemia and the combination thereof enhances the incidence of chronic kidney disease (CKD) in middle-aged and older males. Clin. Exp. Hypertens. 39(7), 645–654 (2017) PubMedCrossRef
41.
Zurück zum Zitat E.L. Schiffrin, M.L. Lipman, J.F. Mann, Chronic kidney disease: effects on the cardiovascular system. Circulation 116(1), 85–97 (2007) PubMedCrossRef E.L. Schiffrin, M.L. Lipman, J.F. Mann, Chronic kidney disease: effects on the cardiovascular system. Circulation 116(1), 85–97 (2007) PubMedCrossRef
43.
Zurück zum Zitat M.J. Knol, T.J. VanderWeele, Recommendations for presenting analyses of effect modification and interaction. Int. J. Epidemiol. 41(2), 514–520 (2012) PubMedPubMedCentralCrossRef M.J. Knol, T.J. VanderWeele, Recommendations for presenting analyses of effect modification and interaction. Int. J. Epidemiol. 41(2), 514–520 (2012) PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat K.J. Rothman, S. Greenland, A.M. Walker, Concepts of interaction. Am. J. Epidemiol. 112(4), 467–470 (1980) PubMedCrossRef K.J. Rothman, S. Greenland, A.M. Walker, Concepts of interaction. Am. J. Epidemiol. 112(4), 467–470 (1980) PubMedCrossRef
Metadaten
Titel
Interaction effect of blood glucose and pressure on the risk of chronic kidney disease: a population-based prospective cohort study
verfasst von
Minzhen Wang
Miao Xia
Hongyan Yang
Desheng Zhang
Yanan Zhao
Yingqian He
Jing Liu
Lulu Zhang
Chun Yin
Yana Bai
Publikationsdatum
02.07.2022
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2022
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03094-9

Weitere Artikel der Ausgabe 2/2022

Endocrine 2/2022 Zur Ausgabe

Neu im Fachgebiet Innere Medizin

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.